BMJ Best Practice provides access to the latest evidence-based information for healthcare professionals, structured around the patient consultation with advice on symptom evaluation, test ordering, treatment approach and follow up. It also offers clinical calculators, patient information leaflets and some procedural videos.
Access is available via an NHS OpenAthens account, and you can also create a personal account to keep track of usage for CPD, or to download the free mobile app.
BMJ Best Practice offers
- Daily updates of evidence summaries covering over 1,000 conditions
- 250 clinical calculators
- 400 patient leaflets
- Procedural videos and images
- Links to BNF and BNF for Children for drug information, and Cochrane Clinical Answers for more evidence
Access
BMJ Best Practice is purchased nationally for access by all NHS organisations in England.
You can use an NHS OpenAthens account. Visit the BMJ Best Practice website and login with your NHS OpenAthens account. If asked for your organisation, select NHS England. You can also use a personal account created whilst logged in with OpenAthens to record usage for CME/CPD points.
Mobile apps are available for Android and iOS devices. These require a personal account to authenticate which can be created whilst logged in with NHS OpenAthens.
Guides
Download our quick reference guide for information on how to access and use BMJ Best Practice.
Latest important updates
- NICE recommends teplizumab to delay progression to stage 3 type 1 diabetes
- Imaging-based artificial intelligence (AI) models for breast cancer risk assessment added to US guidelines
- WHO declares cruise ship outbreak over
- First case outside Africa confirmed amidst highest first-month total of any outbreak
- Guidelines recommend long-acting injectable PrEP and a two-drug ART alternative initial regimen as options during pregnancy and breastfeeding
- US guidance encourages prompt diagnosis and treatment of patients with endometrial cancer.
- US guidance encourages prompt diagnosis and treatment of patients with endometrial cancer.
- UK National Screening Committee recommends against population screening for prostate cancer, but recommends targeted screening
- FDA approves first and only oral option for COVID-19 postexposure prophylaxis
- UK NICE guideline update: adjunctive corticosteroids for severe community-acquired pneumonia (NG250)
